Don’t Miss Out: Top 14 Health Press Releases You Should Read This Week!

The healthcare sector is buzzing with fresh developments that are making waves this week. Here’s a brief overview of some significant press releases that you shouldn’t miss.

1. Lilly Expands Its Pain Pipeline
   Lilly is keen to tackle the challenge of chronic pain, often hard to manage without opioids. Mark Mintun, a senior VP at Lilly, stated that their acquisition of SiteOne is about developing new, non-addictive pain therapies.

2. INDY 500 Stars Highlight Veterans’ Health
   At the Indy 500, an event that attracts massive attention, there was a crucial message about prostate cancer. Veterans are at a higher risk, and early detection can save lives.

3. Shaklee Expands Wellness Line
   Shaklee has acquired Modere’s rights to popular wellness products, including Liquid BioCell® and Trim. This move aims to strengthen their position in the wellness market.

4. Gilgamesh Pharmaceuticals Reports Positive Results
   Positive Phase 2a results for GM-2505, aimed at treating major depressive disorder, show promise. Jonathan Sporn, CEO of Gilgamesh, emphasizes its rapid effect, fitting with current treatment models.

5. Valeris Launches for Life Sciences
   Valeris aims to revolutionize the patient experience by providing data, support services, and healthcare tools, focusing on better patient outcomes.

6. UniXell Biotechnology Treats First Patient
   A patient receiving an experimental therapy for Parkinson’s shared positive experiences, marking a hopeful step in treatment options.

7. Celltrion Receives FDA Approval
   Celltrion’s YUFLYMA® achieved full interchangeability status with Humira, marking a significant milestone in the biosimilar landscape.

8. Pillar Biosciences Funding Success
   Pillar has raised $34.5 million to enhance its clinical testing kit capabilities, striving for broader adoption in the biopharma sector.

9. START and OneOncology Collaborate
   This team aims to make early-phase oncology trials more accessible in community settings, where most cancer patients receive treatment.

10. Apotex Launches First Generic Version of Tasigna
    This new generic offers improved access to treatment for leukemia patients, reflecting a growing trend in affordable healthcare.

These developments highlight the continuous effort in the healthcare industry to innovate and address pressing needs. As we look ahead, staying informed about these advancements can be vital for patients and professionals alike.

Source link

PRNewswire, Modere, Gilgamesh Pharmaceuticals, Juncos Hollinger Racing, healthcare organizations, stem cell treatment